In conclusion, HR can improve the prognosis of patients with intermediate-stage HCC who satisfy the new HR criteria consisting of the up-to-seven criteria, serum albumin level >35 g/L, and serum AFP level <100 μg/L. Here, AFP is linked to hepatocellular carcinoma.